GolinHarris lands Omega Pharma portfolio from Virgo

Omega Pharma has moved its entire portfolio into the new healthcare practice at GolinHarris, following the agency's acquisition of Virgo Healthcare last year.

Nytol: Part of the Omega Pharma porfolio
Nytol: Part of the Omega Pharma porfolio

The pharma company has moved its business out of Virgo and into GolinHarris’ healthcare practice, which opened for business last week. Sian Boisseau, former director of consumer health at Virgo, leads the account.

GolinHarris’ new healthcare team of five is charged with raising awareness of Omega Pharma’s over-the-counter brands, targeting both consumer and trade media, as the company looks to become one of the top three in its sector within five years. 

Omega Pharma’s portfolio includes sleeping aid brand Nytol, pain relief brand Solpadeine, and mosquito repellent Jungle Formula.

While Virgo and GolinHarris’ healthcare practices sit alongside each other within parent company Interpublic Group, Virgo’s offices remain in Richmond. The Omega Pharma account has been moved out of the building to avoid conflicts of interest with Virgo’s other over-the-counter clients, such as Reckitt Benckiser.

Boisseau continues to report to Angie Wiles and Sarah Matthew, joint global healthcare practice leaders at GolinHarris and joint chief executives of Virgo Healthcare.

Wiles said the two agencies would be ‘collaborating where appropriate but [remain] separate where client conflicts exist’. ‘It is a natural but important progression for us to establish a healthcare team within GolinHarris London that can also deliver the uncompromised health comms for which Virgo has become known,’ she added.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in